Cardiomyopathies D009202

Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiomyopathies

Description

A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).   MeSH

Subtype Terms (14)

Arrhythmogenic Right Ventricular Dysplasia
2 approved drugs

Cardiomyopathy, Alcoholic
1 approved drug

Cardiomyopathy, Dilated
49 drugs (27 approved, 22 experimental)

Cardiomyopathy, Hypertrophic
30 drugs (18 approved, 12 experimental)

Cardiomyopathy, Restrictive
 

Chagas Cardiomyopathy
9 drugs (8 approved, 1 experimental)

Diabetic Cardiomyopathies
5 drugs (2 approved, 3 experimental)

Endocardial Fibroelastosis
3 drugs (2 approved, 1 experimental)

Endomyocardial Fibrosis
12 drugs (10 approved, 2 experimental)

Glycogen Storage Disease Type IIb
1 experimental drug

Kearns-Sayre Syndrome
 

Myocardial Reperfusion Injury
23 drugs (18 approved, 5 experimental)

Myocarditis
9 drugs (8 approved, 1 experimental)

Sarcoglycanopathies
 



Organization Involved with Phase 4 Indications (74)

Organization Involved with Phase 3 Indications (60)

Organization Involved with Phase 2 Indications (95)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.